Listed

ICU Medical Inc: Form 10-Q for the period ended Sep 30, 2013

Filed with the SEC on Oct 22, 2013 and accepted by EDGAR at Oct 21, 2013, 19:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-07-01 to 2013-09-30$82.8mus-gaap:Revenues
Revenue9 months2013-01-01 to 2013-09-30$235.8mus-gaap:Revenues
Cost of revenue3 months2013-07-01 to 2013-09-30$41.9mus-gaap:CostOfGoodsSold
Cost of revenue9 months2013-01-01 to 2013-09-30$120.0mus-gaap:CostOfGoodsSold
Gross profit3 months2013-07-01 to 2013-09-30$41.0mus-gaap:GrossProfit
Gross profit9 months2013-01-01 to 2013-09-30$115.8mus-gaap:GrossProfit
Research and development3 months2013-07-01 to 2013-09-30$3.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-01-01 to 2013-09-30$8.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2013-07-01 to 2013-09-30$22.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2013-01-01 to 2013-09-30$68.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2013-07-01 to 2013-09-30$15.4mus-gaap:OperatingIncomeLoss
Operating income9 months2013-01-01 to 2013-09-30$38.4mus-gaap:OperatingIncomeLoss
Income tax3 months2013-07-01 to 2013-09-30$4.6mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-01-01 to 2013-09-30$11.9mus-gaap:IncomeTaxExpenseBenefit
Net income9 months2013-01-01 to 2013-09-30$27.1mus-gaap:ProfitLoss
Diluted EPS3 months2013-07-01 to 2013-09-30$0.72us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-01-01 to 2013-09-30$1.79us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-07-01 to 2013-09-30$0.75us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-01-01 to 2013-09-30$1.85us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-07-01 to 2013-09-3015,324,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-01-01 to 2013-09-3015,139,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-01-01 to 2013-09-30$42.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2013-01-01 to 2013-09-30$15.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-09-30$188.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-09-30$363.8mus-gaap:AssetsCurrent
Total assetsAt period end2013-09-30$468.7mus-gaap:Assets
Current liabilitiesAt period end2013-09-30$27.1mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2013-09-30$432.6mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Shares outstandingAt period end2013-10-1014,734,581 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000883984-13-000048. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.